Smoking cessation in nicotine-dependent patients

Active Ingredient: Bupropion

Indication for Bupropion

Population group: only adults (18 years old or older)

Bupropion is indicated as an aid to smoking cessation in combination with motivational support in nicotine-dependent patients.

For this indication, competent medicine agencies globally authorize below treatments:

150 mg once daily for 6 days and thereafter 150 mg twice daily for 6-8 weeks

For:

Dosage regimens

Oral, 150 milligrams bupropion, once daily, over the duration of 6 days. Afterwards, oral, 150 milligrams bupropion, 2 times daily, over the duration of 6 to 8 weeks. The maximum allowed total dose is 300 milligrams bupropion daily.

Detailed description

It is recommended that treatment is started while the patient is still smoking and a “target stop date” set within the first two weeks of treatment with bupropion, preferably in the second week. The initial dose is 150mg to be taken daily for six days, increasing on day seven to 150 mg twice daily.

There should be an interval of at least 8 hours between successive doses.

The maximum single dose must not exceed 150 mg and the maximum total daily dose must not exceed 300 mg.

Insomnia is a very common adverse event which can be reduced by avoiding bedtime doses of bupropion (provided there is at least 8 hours between doses).

Patients should be treated for 7-9 weeks. If at seven weeks no effect is seen, treatment should be discontinued.

Discontinuing therapy

Although discontinuation reactions are not expected with bupropion, a tapering-off period may be considered.

Dosage considerations

It can be taken with or without food.

150 mg once daily for 7-9 weeks

For:

Dosage regimens

Oral, 150 milligrams bupropion, once daily, over the duration of 7 to 9 weeks.

Detailed description

Bupropion should be used with caution in older people. Greater sensitivity in some older individuals cannot be ruled out. The recommended dose in older people is 150 mg once a day.

Patients should be treated for 7-9 weeks. If at seven weeks no effect is seen, treatment should be discontinued.

Discontinuing therapy

Although discontinuation reactions are not expected with bupropion, a tapering-off period may be considered.

Dosage considerations

It can be taken with or without food.

Active ingredient

Bupropion

Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.

Read more about Bupropion

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.